Launched in 2011, Stella Therapeutics is driving the development of the first safe and effective cure for Glioblastoma multiforme.

Founded by Dr. Nephi Stella, a world renowned pharmacologist with over 20 years experience  in indentifying novel molecular targets and developing small molecules to treat unmet medical disorders.

Stella Therapeutics uses a lean strategy implemented by world renowned experts in both drug  and business development. This strategy promises to significantly expedite the development of The Company’s transformative therapies.